Mast cell sarcoma of the small intestine: A case report

Journal of Clinical Pathology

Volumn 64, Issue 11, 2011, Pages 1035-1037

  Bugalia, Amit ^a   Abraham, Aby ^a   Balasubramanian, Poonkuzhali ^a   Srivastava, Alok ^a   Nair, Sheila ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; IMATINIB; PREDNISOLONE;

ABDOMINAL PAIN; AGED; ANEMIA; ASCITES; CASE REPORT; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEUM RESECTION; ILEUM TUMOR; LETTER; MALE; ONCOGENE C KIT; PRIORITY JOURNAL; SARCOMA;

BONE NEOPLASMS; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MAST-CELL SARCOMA; TIBIA;

EID: 80054918839     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2011-200154     Document Type: Letter

References (8)

1. Brcić L, Vuletić LB, Stepan J, et al. Mast-cell sarcoma of the tibia. J Clin Pathol 2007;60:424-5. (Pubitemid 46596565)
2. Horny HP, Parwaresch MR, Kaiserling E, et al. Mast cell sarcoma of the larynx. J Clin Pathol 1986;39:596-602. (Pubitemid 16069663)
3. Kojima M, Nakamura S, Itoh H, et al. Mast cell sarcoma with tissue eosinophilia arising in the ascending colon. Mod Pathol 1999;12:739-43. (Pubitemid 29354889)
4. Guenther PP, Huebner A, Sobottka SB, et al. Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy. J Pediatr Hematol Oncol 2001;23:134-8. (Pubitemid 32162678)
5. Chott A, Guenther P, Huebner A, et al. Morphologic and immunophenotypic properties of neoplastic cells in a case of mast cell sarcoma. Am J Surg Pathol 2003;27:1013-19. (Pubitemid 36758906)
6. Gotlib J. KIT mutations in mastocytosis and their potential as therapeutic targets. Immunol Allergy Clin North Am 2006;26:575-92. (Pubitemid 44247535)
7. Frost MJ, Ferrao PT, Hughes TP, et al. Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-KIT whereas the kinase domain mutant D816VKit is resistant. Mol Cancer Ther 2002;1:1115-24.
8. Ma Y, Zeng S, Metcalfe DD, et al. The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood 2002;99:1741-4. (Pubitemid 34533049)